electrolyte_notes
TL2 Regular · Seville, ES
Sodium, potassium, magnesium, and the headache that turns out to be dehydration.
Joined 11 November 2024 · last posted 14h
70 posts, newest first. Showing up to 150.
-
Aggregate verification data across the directory, with caveats Replied, post #75 · Sourcing › Independent verification · 27 Jul 2026 · 0 likes Noted, and thank you for writing it out rather than summarising it.
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #74 · Clinical › Prescriber conversations · 25 Jul 2026 · 31 likes Worth separating two things that post #71 runs together. Where you have a specific worry, name it. "I am worried about X" is more useful to a clinician than a series of…
-
Here for the analytics and not much else Replied, post #67 · Lounge › Introductions · 21 Jul 2026 · 1 like Community culture: introductions give you a sense of who is here. Reading a few introduces you to the people and the tone of the community. None of the above is medical…
-
What a reversed-phase purity number actually is Replied, post #76 · Analytics › HPLC & UHPLC · 21 Jul 2026 · 2 likes Answering the question post #72 raises rather than the one it answers. On reversed-phase purity number, the part that usually goes wrong is that the question is asked…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #82 · Sourcing › Red flags · 16 Jul 2026 · 16 likes Where somebody posts a concern, ask what would resolve it before arguing about it. Half of these threads end with a document nobody had asked for. I would want a second…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #118 · Start Here › How to Ask · 11 Jul 2026 · 0 likes Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your working is wrong, and that is impossible if you only…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #70 · Analytics › Home & field testing · 8 Jul 2026 · 17 likes Post #66 and I disagree about the size of the effect, not about the direction. I would put moderate confidence on the mainstream reading of Lateral-flow and…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #114 · Practice › Reconstitution · 7 Jul 2026 · 0 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
A checklist for reading a certificate in under two minutes Replied, post #47 · Analytics › COA interpretation · 24 Jun 2026 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #6 · Sourcing › Independent verification · 7 Jun 2026 · 29 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Transporting a vial for a weekend away — a second dataset Replied, post #75 · Practice › Storage & stability · 7 Jun 2026 · 4 likes Picking up post #72: that is the part I would want checked first. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #16 · Practice › Storage & stability · 30 May 2026 · 7 likes Reconstituted material carried in a bag for a day is a temperature excursion even in a cool climate. Where that matters is cumulative exposure over weeks rather than a…
-
Follow-up: Patterns that reliably precede a problem, documented Replied, post #2 · Sourcing › Red flags · 21 May 2026 · 0 likes Useful. I have added it to my own notes with the date on it.
-
A site rotation scheme that is easy enough to actually follow Replied, post #67 · Practice › Administration · 19 May 2026 · 8 likes Rotate on a fixed sequence rather than choosing each week. A sequence you follow beats a scheme you improvise, and it produces a record you can read back.
-
What changed in 2026, by region — does this still hold? Replied, post #9 · Access › International · 18 May 2026 · 0 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago. The general case…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #19 · Practice › Dosing & titration · 16 May 2026 · 6 likes Building on post #18 rather than restating it. Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others…
-
The "under review" status pill and when a moderator applies it Replied, post #98 · Evidence › Preprints · 27 Apr 2026 · 0 likes Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one. If that reads as…
-
A checklist for reading a certificate in under two minutes Replied, post #10 · Analytics › COA interpretation · 24 Apr 2026 · 7 likes The arithmetic in post #8 is right; the assumption feeding it is the part to check. A chromatogram supplied as a small image is legible for peak shape and not for…
-
Official shortage notices and what they authorise Replied, post #19 · Access › Shortages · 24 Apr 2026 · 0 likes Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing.
-
Sample handling between despatch and injection Replied, post #64 · Analytics › Method validation · 24 Apr 2026 · 0 likes This follows post #61 rather than contradicting it. Why two laboratories may disagree: after validating the same method, they may still report different purity on the…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #51 · Research Methods › N-of-1 designs · 3 Apr 2026 · 24 likes On post #50 — agreed on the reasoning, with one qualification. Confounding in personal experiments: other things change when you start a medication (season, exercise,…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #106 · Meta › Site feedback · 21 Mar 2026 · 8 likes Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report it. Site architecture affects usability. It is worth…
-
Fasting versus non-fasting and which tests care Replied, post #2 · Clinical › Bloodwork · 21 Mar 2026 · 3 likes The opening post is the version of this I will quote in future. One addition. Fasting versus non-fasting has a well-known answer and a correct answer, and the…
-
Reading an interaction checker output critically Replied, post #144 · Practice › Interactions · 12 Mar 2026 · 12 likes Adding a data point of agreement rather than a data point.
-
[2026 update] Availability by country, dated, with primary sources Replied, post #38 · Access › International · 9 Mar 2026 · 0 likes Post #37 is right about the mechanism and I think understates the practical bit. Licensed prescribing: where a compound is approved, prescribing is restricted to…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #37 · Compounds › Tirzepatide · 8 Mar 2026 · 0 likes Post #35 answers the question as asked. The question underneath it is different. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #93 · Practice › Dosing & titration · 20 Feb 2026 · 2 likes Following this. I have the same question and no better information than the first post.
-
Heterogeneity as information rather than as a nuisance Replied, post #81 · Evidence › Meta-analyses · 29 Jan 2026 · 31 likes Building on post #80 rather than restating it. Second-hand on heterogeneity, so weight it accordingly — someone whose method I trust told me this and I have not…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #47 · Practice › Side effects · 17 Jan 2026 · 6 likes On muscle cramps, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Documentation that appears only after payment Replied, post #122 · Sourcing › Red flags · 30 Dec 2025 · 20 likes The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at scale.
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #48 · Practice › Side effects · 28 Dec 2025 · 26 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #54 · Sourcing › Independent verification · 24 Dec 2025 · 18 likes Saving this. It is the version I will quote when the question comes round again.
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #55 · Compounds › Oral incretins · 3 Dec 2025 · 0 likes Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of magnitude different from the injectable. That is a formulation…
-
Specification in the result column: why that is a meaningful error Replied, post #77 · Analytics › COA interpretation · 22 Nov 2025 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Waist circumference technique and its repeatability Replied, post #13 · Outcomes › Progress reports · 4 Nov 2025 · 26 likes An honest declaration on waist circumference technique: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #99 · Start Here › Welcome · 21 Oct 2025 · 0 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #21 · Sourcing › Regulatory · 2 Oct 2025 · 0 likes Adding what did not work for me on compound being unapproved, since the failures never get written up and they are half the useful information.
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #146 · Data & Tools › Datasets · 11 Sep 2025 · 0 likes Post #144 describes the usual case. This is about the unusual one. Independent test results are the most valuable data this community collects, and they are only…
-
What pooling buys you and what it destroys Replied, post #18 · Evidence › Meta-analyses · 8 Sep 2025 · 9 likes Post #14 put the caveat in the right place and I want to underline it. Pooling buys is one of those subjects where the general answer and the answer for a specific case…
-
When a preprint is the best available evidence and we say so Replied, post #146 · Evidence › Preprints · 6 Sep 2025 · 10 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
A request that was declined, and the reasoning — a second dataset Replied, post #13 · Documentation › Wiki requests · 6 Aug 2025 · 15 likes Post #10 is right about the mechanism and I think understates the practical bit. Format suggestions: if you think a maintained page could be clearer in its presentation…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #30 · Compounds › Semaglutide · 21 Jul 2025 · 12 likes My position on semaglutide versus liraglutide is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
The C-cell question: rodent findings and their human context Replied, post #35 · Compounds › Semaglutide · 5 Jul 2025 · 0 likes Worth separating two things this subcategory keeps merging: what the molecule does, which is reasonably well characterised, and what a particular vial contains, which…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #62 · Evidence › Trials · 26 Jun 2025 · 13 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #5 · Analytics › HPLC & UHPLC · 22 Jun 2025 · 17 likes Everything in the opening post holds. The case it does not cover is the one I have. Peaks that do not elute do not appear in the area percentage. Aggregates and…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #36 · Sourcing › Vendor reports · 21 Jun 2025 · 7 likes Saving this. It is the version I will quote when the question comes round again.
-
Cost per milligram, computed honestly across formats — the long version Replied, post #118 · Access › Pricing · 29 May 2025 · 13 likes This follows post #117 rather than contradicting it. Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #34 · Compounds › Cagrilintide & amylin analogues · 24 Apr 2025 · 18 likes Post #31 is right about the mechanism and I think understates the practical bit. Research-use-only cagrilintide is not approved for human use and the published evidence…
-
A report I filed that turned out to be wrong, and the correction Replied, post #25 · Sourcing › Vendor reports · 24 Apr 2025 · 0 likes Report the certificate figure alongside the independent one. The comparison is the point and it is the part most often omitted. Where I would look next, rather than…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #76 · Sourcing › Red flags · 6 Apr 2025 · 0 likes The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at scale.
-
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #3 · Sourcing › Payments · 4 Apr 2025 · 7 likes Building on the opening post rather than restating it. Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has different…
-
Carryover and the ghost peak from last week's standard Replied, post #21 · Analytics › HPLC & UHPLC · 3 Apr 2025 · 16 likes The practical version of carryover is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #49 · Compounds › Tirzepatide · 29 Mar 2025 · 20 likes I had written a reply contradicting post #45 and deleted it. Here is what survived. Before the thread moves on from tirzepatide in type 2 diabetes — what is the sample…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #84 · Analytics › COA interpretation · 30 Jan 2025 · 30 likes Confirming post #81 from a second method, which matters more than confirming it from a second person. An itemised related-substances table with retention times says…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #25 · Evidence › Meta-analyses · 30 Jan 2025 · 26 likes If someone has run Random versus fixed effects properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #61 · Analytics › COA interpretation · 26 Jan 2025 · 0 likes Post #59 put the caveat in the right place and I want to underline it. When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase…
-
Fibre intake when total intake falls, and the constipation link Replied, post #17 · Nutrition & Training › Protein & intake · 15 Jan 2025 · 23 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once. That is the…
-
When "no data" is the complete and final answer Replied, post #66 · Compounds › Other compounds · 14 Jan 2025 · 26 likes Post #62 put the caveat in the right place and I want to underline it. Dose conversions between related compounds in this subcategory are made far too casually.…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #24 · Compounds › Semaglutide · 12 Jan 2025 · 0 likes The 2.4 mg maintenance dose in the weight-management programme and the 1.0 mg diabetes dose are frequently discussed as though they were the same drug at different…
-
Body image changing more slowly than the body Replied, post #112 · Wellbeing › Mental health · 23 Dec 2024 · 21 likes Post #111 is the version of this I will quote in future. One addition. Where a member is finding this hard, the useful reply is usually a question rather than an…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #45 · Sourcing › Regulatory · 3 Dec 2024 · 0 likes I read post #41 twice before replying, because I had assumed the opposite. Research-use-only status is a legal classification, not a safety classification. It means the…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #108 · Compounds › Repair & healing peptides · 21 Nov 2024 · 0 likes Confirming post #107 from a second method, which matters more than confirming it from a second person. The lyophilised cake is worth looking at before adding diluent. A…
-
Melanocortin agonists: mechanism and the documented adverse profile Replied, post #12 · Compounds › Other compounds · 17 Nov 2024 · 0 likes I had written a reply contradicting post #10 and deleted it. Here is what survived. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real…
-
Revisiting: Moderation log format change Replied, post #31 · Meta › Announcements · 17 Nov 2024 · 0 likes Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here.
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #7 · Compounds › Semaglutide · 1 Nov 2024 · 0 likes Post #4 is right about the mechanism and I think understates the practical bit. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly…
-
Pancreatitis history and the risk calculus — a second dataset Replied, post #9 · Safety › Contraindications · 5 Oct 2024 · 0 likes Everything in post #5 holds. The case it does not cover is the one I have. The version of Pancreatitis history that I was taught turned out to be a teaching…
-
Telehealth prescribing models in the US Replied, post #7 · Regional › North America · 24 Sep 2024 · 4 likes Noted, and thank you for writing it out rather than summarising it.
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #52 · Compounds › Semaglutide · 14 Sep 2024 · 29 likes Worth separating two things that post #50 runs together. Offering a way to settle c-cell question rather than another opinion about it. Two measurements, taken the same…
-
Converting between mg/mL and units per dose, both directions Replied, post #4 · marked as the solution · Practice › Reconstitution · 26 Aug 2024 · 7 likes Coming back to post #2, because the follow-up matters more than the original answer. Worked example, since the arithmetic is the whole question. Five milligrams into…
-
The mass-error checker and its intended scope Replied, post #109 · Data & Tools › Calculators · 9 Jul 2024 · 3 likes Reading rather than answering, but this is the post I would point somebody at.